{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T08:11:08Z","timestamp":1779351068606,"version":"3.51.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Acute cardiogenic shock is associated with high mortality rates. The Impella device is a microaxial left ventricular assist device that can be inserted through the axillary artery. The purpose of our study is to determine the role of the Axillary Impella devices on patients with acute cardiogenic shock.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective chart review was conducted to identify patients who underwent Axillary Impella device placement for acute cardiogenic shock from January 1st, 2014 to September 30th, 2018 at a single institution. In-patient records were examined to determine duration of device, length of stay (LOS), postoperative complications, and 30-day in-hospital mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 40 patients, who were primarily men (<jats:italic>N<\/jats:italic>\u2009=\u200929) with a mean age of 61.2\u2009\u00b1\u200910.7\u2009years old, underwent Axillary Impella placement for cardiogenic shock. The primary reasons for implant were (1) required upgraded support from an Impella CP or intra-aortic balloon pump (iabp) to Impella 5.0, (2) to treat left ventricular (LV) distention for patients on extracorporeal mechanical oxygenation (ECMO), and (3) to provide longer term support and allow for mobilization of the patients in whom a device was already indwelling. Twenty-three of the patients had previous devices already in place including a Femoral Impella CP device or an iabp and 9 patients were on ECMO support. The duration of the device was 21.05\u2009\u00b1\u200917\u2009days with the LOS of 40.8\u2009\u00b1\u200928\u2009days for those patients. Seventeen of the patients went on to additional surgery including (1) Heartmate 3 device placement (<jats:italic>N<\/jats:italic>\u2009=\u20096), (2) other cardiac procedures such as surgical revascularization (<jats:italic>N<\/jats:italic>\u2009=\u20099), and orthotopic heart transplantation (<jats:italic>N<\/jats:italic>\u2009=\u20092). A total of 21 patients of the 40 (52%) died during their hospitalization with 7 patients (17%) having complications related to the Impella device. These complications included right arm ischemia or neuropathy (<jats:italic>N<\/jats:italic>\u2009=\u20093) and Impella malfunction requiring device replacement (<jats:italic>N<\/jats:italic>\u2009=\u20094). The majority of these devices were placed in the right axillary artery (<jats:italic>N<\/jats:italic>\u2009=\u200938) versus the left axillary artery (<jats:italic>N<\/jats:italic>\u2009=\u20092).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>A total of 58% (<jats:italic>N<\/jats:italic>\u2009=\u200923) of the study patients had previous mechanical support and 23% (<jats:italic>N<\/jats:italic>\u2009=\u20099) were on ECMO demonstrating the severity of disease and accounting for the high mortality. The Axillary Impella device allows for a minimally invasively placed device that is durable with a mean duration of 3\u2009weeks. The Axillary artery Impella 5.0 provides upgraded full cardiac support while allowing for mobilization of the patient. In addition, it treats LV distention in patients on ECMO while avoiding sternotomy. Finally, the Axillary Impella provides time for decision making for explant, additional therapy with either long-term devices or orthotopic heart transplant.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13019-020-01251-7","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T13:03:00Z","timestamp":1597410180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock"],"prefix":"10.1186","volume":"15","author":[{"given":"Saeed","family":"Tarabichi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohisa","family":"Ikegami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8936-9853","authenticated-orcid":false,"given":"Anthony","family":"Lemaire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,14]]},"reference":[{"issue":"1","key":"1251_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ccl.2017.08.009","volume":"36","author":"SZ Tewelde","year":"2018","unstructured":"Tewelde SZ, Liu SS, Winters ME. Cardiogenic shock. Cardiol Clin. 2018;36(1):53\u201361.","journal-title":"Cardiol Clin"},{"issue":"3","key":"1251_CR2","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","volume":"6","author":"PA Heidenreich","year":"2013","unstructured":"Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6(3):606\u201319.","journal-title":"Circ Heart Fail"},{"issue":"4","key":"1251_CR3","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.amjcard.2019.05.039","volume":"124","author":"CL Rohm","year":"2019","unstructured":"Rohm CL, Gadidov B, Leitson M, Ray HE, Prasad R. Predictors of mortality and outcomes of acute severe cardiogenic shock treated with the Impella device. Am J Cardiol. 2019;124(4):499\u2013504.","journal-title":"Am J Cardiol"},{"issue":"7","key":"1251_CR4","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1002\/ccd.27316","volume":"91","author":"J Ait Ichou","year":"2018","unstructured":"Ait Ichou J, Larivee N, Eisenberg MJ, Suissa K, Filion KB. The effectiveness and safety of the Impella ventricular assist device for high-risk percutaneous coronary interventions: a systematic review. Catheter Cardiovasc Interv. 2018;91(7):1250\u201360.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"1251_CR5","doi-asserted-by":"publisher","first-page":"e004337","DOI":"10.1161\/CIRCINTERVENTIONS.116.004337","volume":"10","author":"A Mandawat","year":"2017","unstructured":"Mandawat A, Rao SV. Percutaneous mechanical circulatory support devices in cardiogenic shock. Circ Cardiovasc Interv. 2017;10(5):e004337.","journal-title":"Circ Cardiovasc Interv"},{"issue":"4","key":"1251_CR6","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jtcvs.2016.10.085","volume":"153","author":"D Yoshioka","year":"2017","unstructured":"Yoshioka D, Takayama H, Garan AR, Topkara VK, Han J, Li B, et al. Bridge to durable left ventricular assist device for refractory cardiogenic shock. J Thorac Cardiovasc Surg. 2017;153(4):752\u201362 e5.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"1251_CR7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/MAT.0000000000000804","volume":"65","author":"OJ Akanni","year":"2019","unstructured":"Akanni OJ, Takeda K, Truby LK, Kurlansky PA, Chiuzan C, Han J, et al. EC-VAD: combined use of extracorporeal membrane oxygenation and percutaneous microaxial pump left ventricular assist device. ASAIO J. 2019;65(3):219\u201326.","journal-title":"ASAIO J"},{"issue":"3","key":"1251_CR8","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.athoracsur.2016.12.049","volume":"104","author":"S Tepper","year":"2017","unstructured":"Tepper S, Masood MF, Baltazar Garcia M, Pisani M, Ewald GA, Lasala JM, et al. Left ventricular unloading by Impella device versus surgical vent during extracorporeal life support. Ann Thorac Surg. 2017;104(3):861\u20137.","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"1251_CR9","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/ejhf.668","volume":"19","author":"F Pappalardo","year":"2017","unstructured":"Pappalardo F, Schulte C, Pieri M, Schrage B, Contri R, Soeffker G, et al. Concomitant implantation of Impella((R)) on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. Eur J Heart Fail. 2017;19(3):404\u201312.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"1251_CR10","first-page":"678","volume":"38","author":"S Subramanian","year":"2011","unstructured":"Subramanian S, Seeburger J, Noack T, Mohr FW. Future perspectives in minimally invasive cardiac surgery. Tex Heart Inst J. 2011;38(6):678\u20139.","journal-title":"Tex Heart Inst J"},{"issue":"17","key":"1251_CR11","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","volume":"363","author":"MB Leon","year":"2010","unstructured":"Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597\u2013607.","journal-title":"N Engl J Med"},{"issue":"3","key":"1251_CR12","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jtcvs.2009.10.047","volume":"139","author":"W Cheng","year":"2010","unstructured":"Cheng W, Fontana GP, De Robertis MA, Mirocha J, Czer LS, Kass RM, et al. Is robotic mitral valve repair a reproducible approach? J Thorac Cardiovasc Surg. 2010;139(3):628\u201333.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"1251_CR13","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.ejvs.2011.08.009","volume":"42","author":"SG Thrumurthy","year":"2011","unstructured":"Thrumurthy SG, Karthikesalingam A, Patterson BO, Holt PJ, Hinchliffe RJ, Loftus IM, et al. A systematic review of mid-term outcomes of thoracic endovascular repair (TEVAR) of chronic type B aortic dissection. Eur J Vasc Endovasc Surg. 2011;42(5):632\u201347.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"6","key":"1251_CR14","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ejvs.2015.02.015","volume":"49","author":"SC van Beek","year":"2015","unstructured":"van Beek SC, Vahl A, Wisselink W, Reekers JA, Legemate DA, Balm R, et al. Midterm re-interventions and survival after endovascular versus open repair for ruptured abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2015;49(6):661\u20138.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"6","key":"1251_CR15","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1007\/s10016-001-0092-x","volume":"15","author":"B Aljabri","year":"2001","unstructured":"Aljabri B, Obrand DI, Montreuil B, MacKenzie KS, Steinmetz OK. Early vascular complications after endovascular repair of aortoiliac aneurysms. Ann Vasc Surg. 2001;15(6):608\u201314.","journal-title":"Ann Vasc Surg"},{"issue":"6","key":"1251_CR16","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1583\/08-2622.1","volume":"16","author":"M Eisenack","year":"2009","unstructured":"Eisenack M, Umscheid T, Tessarek J, Torsello GF, Torsello GB. Percutaneous endovascular aortic aneurysm repair: a prospective evaluation of safety, efficiency, and risk factors. J Endovasc Ther. 2009;16(6):708\u201313.","journal-title":"J Endovasc Ther"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-020-01251-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-020-01251-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-020-01251-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T23:11:21Z","timestamp":1628896281000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-020-01251-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,14]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1251"],"URL":"https:\/\/doi.org\/10.1186\/s13019-020-01251-7","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,14]]},"assertion":[{"value":"27 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"NA","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No financial interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"218"}}